SEPTInvestingStart Free

PEPG 8-K: Secondary offering

PepGen Inc.

Filed with the SEC on · accession 0001193125-26-458597

PEPG filed a 8-K (current report) with the SEC on Nov 12, 2026. PepGen Inc. entered into an underwriting agreement to sell 25,000,000 shares of common stock at $5.00 per share in a public offering, with an option for underwriters to purchase up to 3,750,000 additional shares. The stock moved -4.2% by the first close after the filing.

Summary of the filing

PepGen Inc. entered into an underwriting agreement to sell 25,000,000 shares of common stock at $5.00 per share in a public offering, with an option for underwriters to purchase up to 3,750,000 additional shares. Net proceeds are estimated at approximately $116.9 million, or $134.5 million if the option is fully exercised, to fund clinical development and general corporate purposes.

For details, click here →How to read a 8-K →

Key details

Public offering price per share$5
Number of firm shares offered$25.0M
Estimated net proceeds$116.9M
Estimated net proceeds if over-allotment fully exercised$134.5M
Over-allotment option shares$3.8M
IssuerPepGen Inc.
UnderwriterLeerink Partners LLC
UnderwriterStifel, Nicolaus & Company, Incorporated
UnderwriterGuggenheim Securities, LLC
Legal counselGoodwin Procter LLP
Chief financial officerNoel Donnelly

How PEPG stock reacted

Close before

$5.26

Nov 11, 2026

First close after

-4.18%

$5.04

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for PEPG, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for PEPG?

Click here

Frequently asked questions

What did PEPG file with the SEC on Nov 12, 2026?

PEPG filed a 8-K (Secondary offering). PepGen Inc. entered into an underwriting agreement to sell 25,000,000 shares of common stock at $5.00 per share in a public offering, with an option for underwriters to purchase up to 3,750,000 additional shares. Net proceeds are estimated at approximately $116.9 million, or $134.5 million if the option is fully exercised, to fund clinical development and general corporate purposes.

What does a secondary offering mean for PEPG stock?

New shares dilute existing holders and are often sold at a discount to the market price.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did PEPG stock react to this filing?

PEPG closed at $5.26 before the filing and $5.04 on Nov 12, 2026 (-4.18%).

Other PEPG SEC filings

Get alerts when PEPG files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
PEPG overviewPEPG analysisPEPG newsLatest SEC filings